Basic Information | Post buying leads | Suppliers |
Name |
N-Diazoacetylglycine hydrazide |
EINECS | N/A |
CAS No. | 820-75-7 | Density | 1.5005 (rough estimate) |
PSA | 121.61000 | LogP | -1.04374 |
Solubility | N/A | Melting Point |
N/A |
Formula | C4H7 N5 O2 | Boiling Point | 281.77°C (rough estimate) |
Molecular Weight | 157.132 | Flash Point | N/A |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by intravenous route. Moderately toxic by ingestion, intraperitoneal, and subcutaneous routes. Questionable carcinogen with experimental carcinogenic and neoplastigenic data. Mutation data reported. When heated to decomposition it emits toxic fumes including NOx. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Glycine,N-(diazoacetyl)-, hydrazide (7CI,8CI,9CI); Diazoacetylglycine hydrazide;N-(Diazoacetyl)glycine hydrazide |
Product Name: N-Diazoacetylglycine hydrazide (CAS NO.820-75-7)
Molecular Formula: C4H7N5O2
Molecular Weight: 157.16g/mol
Mol File: 820-75-7.mol
XLogP3-AA: 0.2
H-Bond Donor: 3
H-Bond Acceptor: 5
Structure Descriptors of N-Diazoacetylglycine hydrazide (CAS NO.820-75-7):
IUPAC Name: (Z)-2-diazonio-1-[(2-hydrazinyl-2-oxoethyl)amino]ethenolate
Canonical SMILES: C(C(=O)NN)NC(=C[N+]#N)[O-]
Isomeric SMILES: C(C(=O)NN)N/C(=C/[N+]#N)/[O-]
InChI: InChI=1S/C4H6N5O2/c5-8-2-3(10)7-1-4(11)9-6/h2,6-7,10H,1H2/q-1/p+1/b3-2-
InChIKey: WLRJOPROJKADBZ-IHWYPQMZSA-O
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LDLo | intravenous | 39mg/kg (39mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA GASTROINTESTINAL: NAUSEA OR VOMITING | Cancer Chemotherapy Reports, Part 1. Vol. 53, Pg. 13, 1969. |
mouse | LD50 | intraperitoneal | 2575mg/kg (2575mg/kg) | GASTROINTESTINAL: OTHER CHANGES LIVER: OTHER CHANGES KIDNEY, URETER, AND BLADDER: OTHER CHANGES | Cancer Chemotherapy Reports, Part 1. Vol. 53, Pg. 13, 1969. |
mouse | LD50 | oral | 3852mg/kg (3852mg/kg) | GASTROINTESTINAL: OTHER CHANGES | Cancer Chemotherapy Reports, Part 1. Vol. 53, Pg. 13, 1969. |
mouse | LD50 | subcutaneous | 2985mg/kg (2985mg/kg) | LUNGS, THORAX, OR RESPIRATION: EMPHYSEMA CARDIAC: OTHER CHANGES GASTROINTESTINAL: OTHER CHANGES | Cancer Chemotherapy Reports, Part 1. Vol. 53, Pg. 13, 1969. |
rabbit | LDLo | intravenous | 833mg/kg (833mg/kg) | BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Cancer Chemotherapy Reports, Part 1. Vol. 53, Pg. 13, 1969. |
rat | LD50 | intraperitoneal | 1335mg/kg (1335mg/kg) | LUNGS, THORAX, OR RESPIRATION: EMPHYSEMA BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Cancer Chemotherapy Reports, Part 1. Vol. 53, Pg. 13, 1969. |
rat | LD50 | intravenous | 1595mg/kg (1595mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: CYANOSIS LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Cancer Chemotherapy Reports, Part 1. Vol. 53, Pg. 13, 1969. |
EPA Genetic Toxicology Program.
Poison by intravenous route. Moderately toxic by ingestion, intraperitoneal, and subcutaneous routes. Questionable carcinogen with experimental carcinogenic and neoplastigenic data. Mutation data reported. When heated to decomposition it emits toxic fumes including NOx.
N-Diazoacetylglycine hydrazide ,its CAS NO. is 820-75-7,the synonyms is AI3-52380 ; CCRIS 929 ; DGI ; Diazoacetylglycine hydrazide ; N-(Diazoacetyl)glycine hydrazine ; N-Diazoacetilglicina-idrazide ; N-Diazoacetyl glycyclhydrazide ; NSC 58404 ; Glycine, N-(diazoacetyl)-, hydrazide .